胎儿心脏重构与功能障碍与子痫前期及胎儿生长受限均相关
一项前瞻性观察研究比较了血压正常的胎儿生长受限、子痫前期且胎儿生长正常、子痫前期合并胎儿生长受限及111例无并发症妊娠的胎儿心脏结构与功能。结果显示子痫前期和/或胎儿生长受限均呈现相似的心脏重构及功能障碍模式,且与胎儿生长模式无关。
要点
- 子痫前期和/或胎儿生长受限的胎儿均出现心脏增大、右心室更呈球形及心室肥厚。
- 这些妊娠还表现出心肌功能障碍迹象,如心肌性能指数升高及脐血B型利钠肽和肌钙蛋白I升高。
- 子痫前期母亲的胎儿无论生长模式如何,均表现出与胎儿生长受限相似的心血管重构和功能障碍。
核心结论
- 子痫前期母亲的胎儿,无论其生长模式如何,均表现出与先前描述的胎儿生长受限相似的心血管重构和功能障碍。
- 未来需要进一步研究以更好地阐明这些情况下胎儿心脏适应的机制。
研究设计与样本
- 这是一项前瞻性观察性研究,纳入血压正常的胎儿生长受限妊娠(n=36)、子痫前期且胎儿生长正常的妊娠(n=35)、子痫前期合并胎儿生长受限的妊娠(n=42),以及111例按超声时孕龄匹配的无并发症妊娠。
- 病例在诊断时、无并发症妊娠在招募时进行胎儿超声心动图检查,分娩时测量脐血B型利钠肽和肌钙蛋白I浓度,并进行单变量和多变量回归分析。
主要发现
- 心胸比中位数(四分位距):无并发症妊娠0.27(0.23-0.29),胎儿生长受限0.31(0.26-0.34),子痫前期且胎儿生长正常0.31(0.29-0.33),子痫前期合并胎儿生长受限0.28(0.26-0.33),P<.001。
- 右心室球形指数中位数(四分位距):无并发症妊娠1.42(1.25-1.72),胎儿生长受限1.29(1.22-1.72),子痫前期且胎儿生长正常1.30(1.33-1.51),子痫前期合并胎儿生长受限1.35(1.27-1.46),P=.04。
- 相对室壁厚度中位数(四分位距):无并发症妊娠0.55(0.48-0.61),胎儿生长受限0.67(0.58-0.8),子痫前期且胎儿生长正常0.68(0.61-0.76),子痫前期合并胎儿生长受限0.66(0.58-0.77),P<.001。
- 心肌性能指数z评分中位数(四分位距):无并发症妊娠0.78(0.32-1.41),胎儿生长受限1.48(0.97-2.08),子痫前期且胎儿生长正常1.15(0.75-2.17),子痫前期合并胎儿生长受限0.45(0.54-1.94),P<.001。
- 脐血B型利钠肽中位数(四分位距):无并发症妊娠14.2(8.4-30.9)pg/mL,胎儿生长受限20.8(13.1-33.5)pg/mL,子痫前期且胎儿生长正常31.8(16.4-45.8)pg/mL,子痫前期合并胎儿生长受限37.9(15.7-105.4)pg/mL,P<.001;脐血肌钙蛋白I也较无并发症妊娠升高。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Preeclampsia and fetal growth restriction share some pathophysiologic features and are both associated with placental insufficiency. Fetal cardiac remodeling has been described extensively in fetal growth restriction, whereas little is known about preeclampsia with a normally grown fetus. OBJECTIVE: To describe fetal cardiac structure and function in pregnancies complicated by preeclampsia and/or fetal growth restriction as compared with uncomplicated pregnancies. STUDY DESIGN: This was a prospective, observational study including pregnancies complicated by normotensive fetal growth restriction (n=36), preeclampsia with a normally grown fetus (n=35), preeclampsia with fetal growth restriction (preeclampsia with a normally grown fetus-fetal growth restriction, n=42), and 111 uncomplicated pregnancies matched by gestational age at ultrasound. Fetal echocardiography was performed at diagnosis for cases and recruitment for uncomplicated pregnancies. Cord blood concentrations of B-type natriuretic peptide and troponin I were measured at delivery. Univariate and multiple regression analysis were conducted. RESULTS: Pregnancies complicated by preeclampsia and/or fetal growth restriction showed similar patterns of fetal cardiac remodeling with larger hearts (cardiothoracic ratio, median [interquartile range]: uncomplicated pregnancies 0.27 [0.23-0.29], fetal growth restriction 0.31 [0.26-0.34], preeclampsia with a normally grown fetus 0.31 [0.29-0.33), and preeclampsia with fetal growth restriction 0.28 [0.26-0.33]; P<.001) and more spherical right ventricles (right ventricular sphericity index: uncomplicated pregnancies 1.42 [1.25-1.72], fetal growth restriction 1.29 [1.22-1.72], preeclampsia with a normally grown fetus 1.30 [1.33-1.51], and preeclampsia with fetal growth restriction 1.35 [1.27-1.46]; P=.04) and hypertrophic ventricles (relative wall thickness: uncomplicated pregnancies 0.55 [0.48-0.61], fetal growth restriction 0.67 [0.58-0.8], preeclampsia with a normally grown fetus 0.68 [0.61-0.76], and preeclampsia with fetal growth restriction 0.66 [0.58-0.77]; P<.001). Signs of myocardial dysfunction also were observed, with increased myocardial performance index (uncomplicated pregnancies 0.78 z scores [0.32-1.41], fetal growth restriction 1.48 [0.97-2.08], preeclampsia with a normally grown fetus 1.15 [0.75-2.17], and preeclampsia with fetal growth restriction 0.45 [0.54-1.94]; P<.001) and greater cord blood B-type natriuretic peptide (uncomplicated pregnancies 14.2 [8.4-30.9] pg/mL, fetal growth restriction 20.8 [13.1-33.5] pg/mL, preeclampsia with a normally grown fetus 31.8 [16.4-45.8] pg/mL and preeclampsia with fetal growth restriction 37.9 [15.7-105.4] pg/mL; P<.001) and troponin I as compared with uncomplicated pregnancies. CONCLUSION: Fetuses of preeclamptic mothers, independently of their growth patterns, presented cardiovascular remodeling and dysfunction in a similar fashion to what has been previously described for fetal growth restriction. Future research is warranted to better elucidate the mechanism(s) underlying fetal cardiac adaptation in these conditions.
引用
- Youssef L, Miranda J, Paules C, et al. Fetal cardiac remodeling and dysfunction is associated with both preeclampsia and fetal growth restriction. Am J Obstet Gynecol. 2019. PMID: 31336074. doi:10.1016/j.ajog.2019.07.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。